To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Reoffenders: Mental Health Services
Tuesday 11th November 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what proportion of repeat offenders have access to specialist (a) mental health and (b) substance misuse treatment while in custody.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

People in prison are entitled to the same standard and range of health and social care services as they would receive in the community. All prisoners, regardless of whether or not they are repeat offenders, should have access to integrated mental health services. This includes access to a range of treatments and interventions within prison.

We are committed to ensuring that all offenders can access high-quality treatment that enables them to recover from their problems with drug or alcohol use as quickly as possible. We will continue to ensure that the full range of evidence-based treatment interventions is available to address the wide range of drug needs presented by people in secure and community settings, including abstinence-based interventions to support recovery from drug dependency.


Written Question
Lung Cancer: Screening
Monday 10th November 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of the (a) level of rollout completion and (b) uptake rates of lung cancer screening programmes in each area where those services have been commissioned.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The National Lung Cancer Screening Programme is designed to identify lung cancer at an earlier stage, particularly among people at highest risk. The programme offers screening to individuals aged 55 to 74 years old with a history of smoking, recognising that lung cancer disproportionately affects people living in more deprived areas.

The National Health Service is currently rolling out the programme across England. The Public Health Functions Agreement between the Department and NHS England sets a target to invite 50% of the eligible population by March 2026, with full implementation planned by the end of the decade.

To encourage uptake of lung screening, the NHS in England is directly targeting activity at areas that we know will make a difference. This includes awareness campaigns such as the NHS Help Us, Help You campaign, to increase awareness of cancer symptoms, including lung cancer, and encourage people to get checked.


Written Question
Palliative Care: Access
Monday 27th October 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure equality of access to palliative care across England.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

Palliative care services are included in the list of services an integrated care board (ICB) must commission. To support ICBs in this duty, NHS England has published statutory guidance and service specifications.  The statutory guidance states that ICBs must work to ensure that there is sufficient provision of care services to meet the needs of their local populations.

NHS England has also developed a palliative care and end of life care dashboard, which brings together all relevant local data in one place. The dashboard helps commissioners understand the palliative care and end of life care needs of their local population, enabling ICBs to put plans in place to address and track the improvement of health inequalities, and ensure that funding is distributed fairly, based on prevalence.

The Department and NHS England are currently looking at how to improve the access, quality, and sustainability of all-age palliative care and end of life care in line with the 10-Year Health Plan.

We will closely monitor the shift towards the strategic commissioning of palliative care and end of life care services to ensure that services reduce variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations.

Additionally, through the National Institute for Health and Care Research, the Department is investing £3 million in a Policy Research Unit in Palliative and End of Life Care. This unit, launched in January 2024, is building the evidence base on palliative care and end of life care, with a specific focus on inequalities.

Whilst the majority of palliative care and end of life care is provided by National Health Service staff and services, we recognise the vital part charitable hospices play as well. This is why we are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.

We are also providing £26 million in revenue funding to support children and young people’s hospices for 2025/26.  I am pleased to confirm the continuation of this vital funding for the next three financial years, from 2026/27 to 2028/29 inclusive. This funding will see approximately £26 million, adjusted for inflation, allocated to children and young people’s hospices in England each year, via their local ICBs on behalf of NHS England, as happened in 2024/25 and 2025/26.  This amounts to approximately £80 million over the next three years.


Written Question
Hospices: Contracts
Monday 27th October 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that hospice contracts reflect the (a) cost of the services they provide and (b) needs of their local populations.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

Integrated care boards (ICBs) are responsible for the commissioning of palliative care and end of life care services, to meet the needs of their local populations. To support ICBs in this duty, NHS England has published statutory guidance and service specifications.  NHS England has also developed a palliative care and end of life care dashboard, which brings together all relevant local data in one place. The dashboard helps commissioners understand the palliative care and end of life care needs of their local population.

Whilst the majority of palliative care and end of life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people at the end of life, and their loved ones.

Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding each charitable hospice receives varies both within and between ICB areas. This will vary depending on demand in that ICB area but will also be dependent on the totality and type of palliative and end of life care provision from both NHS and non-NHS services, including charitable hospices, within each ICB area.

The Department and NHS England are currently looking at how to improve the access, quality, and sustainability of all-age palliative care and end of life care in line with the 10- Year Health Plan. We will closely monitor the shift towards the strategic commissioning of palliative care and end of life care services to ensure that services reduce variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations.

Additionally, we are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.

We are also providing £26 million in revenue funding to support children and young people’s hospices for 2025/26.  I am pleased to confirm the continuation of this vital funding for the next three financial years, from 2026/27 to 2028/29 inclusive. This funding will see approximately £26 million, adjusted for inflation, allocated to children and young people’s hospices in England each year, via their local ICBs on behalf of NHS England, as happened in 2024/25 and 2025/26.  This amounts to approximately £80 million over the next three years.


Written Question
Cervical Cancer: Screening
Friday 24th October 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the accessibility of cervical screening in the context of the proposed merging of Integrated Care Boards.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The merging of smaller integrated care boards will help to ensure that they have the capacity and capability to be effective strategic commissioners for all the services for the local population for which they are responsible, including elements of cervical screening.


Written Question
Human Papillomavirus: Vaccination
Friday 24th October 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what progress he has made on the roll out of HPV vaccination through community pharmacies for people who missed out at school.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving vaccine uptake and access across all immunisation programmes by exploring new and innovative delivery models, including expanding routes such as community pharmacies, as set out in the NHS Vaccination Strategy and the 10-Year Health Plan for England.

The Department is working with the UK Health Security Agency and NHS England to develop options for delivering human papilloma virus catch-up vaccination through community pharmacies from 2026, with the ambition to increase uptake among younger adults who have left school, supporting our aim to eliminate cervical cancer by 2040.


Written Question
Lung Cancer: Screening
Tuesday 14th October 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what proportion of the country has access to the national lung cancer screening programme.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The National Health Service will build on its recent successes, including roll-out of the National Lung Cancer Screening Programme, to diagnose cancer earlier and boost survival rates. Funding for national lung screening is set by NHS England and the timescale for full implementation of the National Lung Cancer Screening Programme will be specified in due course.

The NHS is currently rolling out the National Lung Cancer Screening Programme to people with a history of smoking. The public health functions agreement between NHS England and the Department sets out that the Lung Cancer Screening Programme has a target to invite 50% of the eligible population by the end of March 2026.


Written Question
Endometriosis
Thursday 25th September 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve GP (a) training in and (b) awareness of (i) endometriosis and (ii) women’s health issues in general.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

General practitioners (GPs) are responsible for ensuring that their own clinical knowledge, including on endometriosis and women’s health issues in general, remains up-to-date, and for identifying learning needs as part of their continuing professional development.

All United Kingdom registered doctors are expected to meet the professional standards set out in the General Medical Council’s (GMC’s) Good Medical Practice. The training curriculum for postgraduate trainee doctors is set by the Royal College of General Practitioners, and must meet the standards set by the GMC.

The GMC has introduced the Medical Licensing Assessment to encourage a better understanding of common women’s health problems among all doctors as they start their careers in the UK. The content map for this assessment includes several topics relating to women’s health including menstrual problems, endometriosis, menopause and urinary incontinence. This will encourage a better understanding of common women’s health problems among all doctors as they start their careers in the UK. Endometriosis is also included in the core curriculum for trainee GPs, and for obstetricians and gynaecologists.

In November 2024, the National Institute for Health and Care Excellence updated their guideline on endometriosis which makes firmer recommendations for healthcare professionals on referral and investigations for women with suspected diagnosis. This guidance is available at the following link:

https://www.nice.org.uk/guidance/ng73


Written Question
Cancer: Genomics
Monday 22nd September 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the capacity in the whole genome sequencing programme for the treatment of less survivable cancers.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Genomic testing in the National Health Service in England is provided through the NHS Genomic Medicine Service (GMS) as directed by the National Genomic Test Directory (NGTD), which includes tests for over 7,000 rare diseases with an associated genetic cause and over 200 cancer clinical indications, including both whole genome sequencing (WGS) and non-WGS testing. The NGTD sets out the eligibility criteria for patients to access testing as well as the genomic targets to be tested and the method that should be used.

WGS is available on the NGTD for all paediatric and central nervous system tumours where there is a clear, clinical question and where results have expected utility/impact. WGS for all other adult solid tumours, including less survivable cancers, can be performed where there is a clinical need and where results are likely to change clinical management.


Written Question
Endometriosis
Friday 19th September 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to (a) mental health and (b) pain management support for people with endometriosis.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Long wait times are a feature of a system in desperate need of change. On mental health, we are already responding by delivering new, innovative models of care in the community, including piloting six neighbourhood adult mental health centres, operating 24 hours a day, seven days a week, to bring together community, crisis and inpatient care.

We are also recruiting an additional 8,500 mental health workers to ensure people can access treatment and support earlier with 6,700 of these having been recruited since July 2024. We are prioritising expansions of Talking Therapies and Individual Placement and Support schemes, supporting those with mild to moderate mental illness through earlier intervention.

Additionally, the National Institute for Health and Care Research, the research delivery arm of the Department, funds a range of research to support women’s health conditions, including endometriosis. Funding has been awarded to studies seeking to improve outcomes for women with endometriosis by better understanding the condition, enabling earlier diagnosis, and evaluating current and emerging treatment options. This includes research on mental health and pain management support for people with endometriosis.